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Evaluating women's knowledge of the combined oral contraceptive pill in
an Australian rural general practice setting
Abstract
Background: In addition to the contraceptive action of the combined oral contraceptive pill (COCP), there
are a number of other benefits to its use such as menstrual cycle regulation. However, COCP use is also
associated with a higher risk of thromboembolism. Despite the prevalence of COCP use, studies have
indicated that overall women have poor knowledge of the COCP.
Aim: To evaluate women's knowledge of the COCP in a rural general practice setting. The extent of
knowledge was assessed in several domains including: COCP use and effectiveness, mechanism of action, and
the risks and benefits of COCP use.
Methods: An observational study design was utilised. Women aged 18-50 years self-selected to complete an
anonymous survey at a general practice in rural NSW. Women who were currently using, had previously used,
or had never used the COCP were invited to participate. Women using a progesterone-only contraceptive
were excluded. A total knowledge score on the usage and effects of the COCP was calculated for each
participant by assessing responses to 34 questions for an overall score out of 34.
Results: A total of 80 surveys were completed revealing that 98% of respondents used the COCP at some
time in their lives with almost 29% being current users. The mean total knowledge score for all participants
was 14.4 (SD = 4.9) out of a possible 34 (range: 5 - 26). There was no significant difference in total knowledge
score between current and previous users (p = 0.56).
Conclusion: The women surveyed in this study appear to have substantial gaps in their knowledge of the
COCP. This study provides insight into specific knowledge areas that require further education and
clarification during COCP counselling sessions (especially those conducted by a GP) to encourage improved
knowledge of the COCP by women in this particular setting.
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Introduction
The combined oral contraceptive pill (COCP) is an oral hormonal 
contraceptive that contains synthetic oestrogen and progesterone. 
Since it was first made  available in Australia in 1961, the COCP has 
become the principal contraceptive method of choice among Australian 
women [1]. Contraceptive management is a common reason for GP 
consultation, with the COCP being the most frequently prescribed 
contraceptive [1].
Though it is well known for its contraceptive action, there are a 
number of additional benefits associated with COCP use [2-11]. There 
is decreased risk of ovarian and endometrial cancers [2,3,5,6] and 
reduced risk of benign breast disease, functional ovarian cysts, ectopic 
pregnancies, and pelvic inflammatory disease [2-4,7]. The COCP is 
also beneficial in that it helps to regulate the menstrual cycle, and 
reduces dysmenorrhoea, menorrhagia, and endometriosis-associated 
pain [2,3,8,9]. Acne and the effects of hyperandrogenism may also be 
minimised with COCP use [2-4,10].
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Background: In addition to the contraceptive action of the combined 
oral contraceptive pill (COCP), there are a number of other benefits 
to its use such as menstrual cycle regulation. However, COCP use 
is also associated with a higher risk of thromboembolism. Despite 
the prevalence of COCP use, studies have indicated that overall 
women have poor knowledge of the COCP.
Aim: To evaluate women’s knowledge of the COCP in a rural general 
practice setting. The extent of knowledge was assessed in several 
domains including: COCP use and effectiveness, mechanism of 
action, and the risks and benefits of COCP use.  
Methods:  An observational study design was utilised. Women aged 
18-50 years self-selected to complete an anonymous survey at a 
general practice in rural NSW. Women who were currently using, 
had previously used, or had never used the COCP were invited to 
participate. Women using a progesterone-only contraceptive were 
excluded. A total knowledge score on the usage and effects of the 
COCP was calculated for each participant by assessing responses to 
34 questions for an overall score out of 34. 
Results: A total of 80 surveys were completed revealing that 98% 
of respondents used the COCP at some time in their lives with 
almost 29% being current users. The mean total knowledge score 
for all participants was 14.4 (SD = 4.9) out of a possible 34 (range: 
5 - 26). There was no significant difference in total knowledge score 
between current and previous users (p = 0.56). 
Conclusion: The women surveyed in this study appear to have 
substantial gaps in their knowledge of the COCP. This study provides 
insight into specific knowledge areas that require further education 
and clarification during COCP counselling sessions (especially those 
conducted by a GP) to encourage improved knowledge of the COCP 
by women in this particular setting.
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Despite these many benefits, there are several risks associated with 
COCP use. The introduction of low-dose COCPs saw a significant 
improvement in its safety profile, particularly in the reduction of 
thromboembolism [2,3]. Nonetheless, COCP use does increase the risk 
of thromboembolism, stroke, and myocardial infarction [2,3,12,13]. 
This is a rare complication in otherwise healthy women [2]. Women 
over the age of 35, smokers, and women who are obese have a higher 
risk of thromboembolism with COCP use [11,14]. The evidence is mixed 
as to whether the COCP increases the risk of breast cancer [2,15]. The 
current consensus is that the COCP does increase risk, but this risk is 
considered to be very small (equal to approximately one extra case per 
year for every 100,000 women) and becomes negligible ten years after 
cessation of use [15,16], however, research is still ongoing.
The COCP has been shown to be a very effective contraceptive with 
perfect use (the failure rate is 0.3%), however, its typical-use failure 
rate is as high as 9% [17,18]. These figures were generated by an 
American study by Trussell [18] and are frequently utilised in Australian 
literature. The typical-use rate is most commonly attributed to incorrect 
or inconsistent use [2]. Thus, unplanned pregnancy is an important risk 
for women taking the COCP to consider. There is little data to suggest 
that sound knowledge of the COCP correlates to improved behavioural 
changes and related outcomes such as unintended pregnancies [19,20]. 
Nevertheless, a better understanding of this common medication 
is likely to be a significant contributing factor in the reduction of the 
current failure rate which is why studies assessing women’s knowledge 
of the COCP are important.
Research conducted in a diverse range of settings has indicated that 
women’s knowledge of the COCP is generally poor [11,19,21-24]. A 
comprehensive search of the current literature, however, revealed a 
paucity of studies focusing on such knowledge amongst rural Australian 
women, with only one Australian study focusing on women’s knowledge 
of the COCP from a national perspective [11]. Furthermore, there 
were no international studies focusing on a rural perspective in their 
study populations. As such, this study aimed to evaluate the level of 
knowledge women attending an Australian rural general practice have 
regarding the COCP. The extent of knowledge was assessed through 
several domains including: COCP use and effectiveness, mechanism of 
action, and the potential risks and benefits of COCP use.
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Methods
Participants
Participants eligible for inclusion were women of reproductive age, 
between 18 and 50 years, who were patients of a New South Wales 
rural general practice, and who attended the practice during the study 
period. Women who were currently using or had previously used the 
COCP were invited to participate, as were women who had never taken 
the COCP. Male patients and women taking a progesterone-only oral 
contraceptive were excluded from this study due to the nature of the 
research question. A total of 80 responses were collected and all were 
used in data analysis.
Study design and survey 
This study utilised an observational study design through the provision 
of a survey to participants. The survey included two basic demographic 
questions (age and level of education) and five questions assessing 
personal COCP usage patterns. The questions assessing knowledge 
covered several domains including: COCP use and effectiveness, 
mechanism of action, and the potential risks and benefits of COCP use. 
Additionally, participants were asked about their information sources 
regarding the COCP. 
Recruitment and data collection
Women attending the medical practice self-selected to complete the 
survey. Participant information sheets were attached to each survey 
and were made available at the reception desk of the practice. Posters 
advertising the survey were also displayed in the waiting room area. 
Participation was entirely voluntary and anonymous, with consent 
being implied from completion of the survey. Completed surveys were 
returned to a secure box at the reception desk, with access to returned 
surveys and subsequent generated data being limited exclusively to 
the lead researcher. Data collection occurred between October and 
December 2014.
Ethics approval was granted by the University of Wollongong (UoW) 
Human Research Ethics Committee in collaboration with the UoW 
Graduate School of Medicine.
Statistical analysis 
Survey data was processed using Microsoft Excel™. P-values were 
calculated for correct scores between current and previous COCP users 
using z-scores with a significance level of ≤ 0.05. 
A “total knowledge score” was also calculated for each participant by 
combining the total marks for questions 8, 10, and 11 of the survey, 
where one mark was awarded to each correct response. Question 8 
comprised a total of 6 sub-questions, question 10 comprised 13 and 
question 11 had 15. As such, the maximum possible score for these 
questions was 34. The mean total knowledge score was subsequently 
calculated by averaging the values amongst all the participants. The 
total knowledge scores of current COCP users versus previous users 
were analysed using the Mann-Whitney “U test” with a significance 
level of ≤ 0.05.
For the purpose of this study, a score of 80% or above for each individual 
response item was designated as an adequate level of knowledge.
Results
Sample characteristics 
In total, 80 responses were received during the study period. Table 1 
shows basic demographic information of the study participants. The 
mean age of the sample was 32.1 years (standard deviation = 8.8). 
Personal COCP usage information
Of the respondents, 98% (n = 78) had taken the COCP at some point 
in their lives (question 3 of the survey). Further information regarding 
usage for women who had previously or were currently taking the 
COCP is listed in Table 2. Women who had never taken the COCP were 
not required to complete these questions (questions 4 to 7).
Knowledge domains
1.  COCP use and effectiveness
Participants were asked to complete questions that assessed their 
general knowledge of the COCP and of what factors may reduce the 
COCPs contraceptive effect. 
In terms of general knowledge (question 8 of the survey), 96% of 
participants correctly identified that the COCP needs to be taken every 
day to serve as effective contraceptive, with 94% correctly identifying 
that it should be taken at the same time every day. Only 28% of women 
were aware that the COCP is not the most effective contraceptive 
currently available with 13% of current COCP users selecting the 
correct answer (compared to 35% of previous users). 
Of the factors that may reduce the contraceptive effect of the COCP 
(question 10), missing one active pill by more than 12 hours and 
missing more than one active pill was correctly identified by 84% and 
94% of women respectively. Other factors that potentially reduce 
contraceptive effect (with percentage of participants selecting the 
correct response in brackets) are as follows: St John’s wort (20%), 
epilepsy medications (14%), vomiting (79%), and severe diarrhoea 
(61%). Two-thirds of women incorrectly identified that antibiotics 
(other than rifampicin and rifabutin) may be a factor that reduces 
contraceptive benefit. There was no significant difference in the 
number of participants selecting the correct response between 
current and previous COCP users for each of the factors investigated. 
Participant responses are further detailed in Table 3. 
2.  Mechanism of action
Only 58% of women surveyed correctly identified that the COCP acts 
to prevent ovulation; this represented 44% of current COCP users 
and 64% of previous COCP users. Furthermore, only 3% of the study 
sample correctly identified all three mechanisms of action (preventing 
ovulation, thickening of cervical mucus, and helping to prevent 
adherence of the embryo to the endometrium). 
3.  Risks and benefits of COCP use
Frequencies of responses to questions assessing knowledge of the 
potential risks and benefits of the COCP are shown in Table 4. The 
conditions in which COCP use may be beneficial (with the percentages 
of participants selecting the correct responses listed in brackets) were 
as follows:  menstrual disturbances (60%), acne (56%), endometriosis-
associated pain (28%), ectopic pregnancy (9%), and ovarian and 
endometrial cancer (6%). Fifty-nine percent of women correctly 
identified that the COCP has no effect on the risk of contracting a 
sexually transmitted infection (STI). Furthermore, weight gain was 
incorrectly identified as a risk associated with taking the COCP by 
75% of women with only 5% of participants selecting the correct 
answer of “no effect”. COCP use increases the risk of cardiovascular 
disease which 39% of women correctly identified. For the majority of 
these questions, “don’t know” was the response selected by a large 
proportion of participants. 
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Table 2. Usage information for women who are currently using or have 
previously used the COCP.
Table 3. Participant responses to general knowledge questions relating to the COCP and factors that may reduce its contraceptive action.










Year 10 18 (23%)
Year 12 24 (30%)
Undergraduate degree 16 (20%)
Postgraduate degree 6 (8%)
TAFE qualification 12 (15%)
Other 4 (5%)
Variable n (%*)
Q4. Current COCP usage (n = 78)
Yes 23 (29%)
No 55 (69%)
Q5. Duration of COCP usage (n = 77)
< 1 year 5 (6%)
1 – 5 years 29 (36%)
5 – 10 years 17 (21%)
> 10 years 26 (33%)
Q6. Has an active tablet ever been 
missed? (n = 78)
Yes 64 (80%)
No 13 (16%)
Don’t Know 1 (1%)
Q7. Frequency of missing an active 
tablet (n = 77)
Never 12 (15%)
Only one time 4 (5%)
Once a year 11 (14%)
Once every few months 30 (38%)
Once a month 16 (20%)
Once a week 4 (5%)













Q8. General knowledge (* indicates the correct answer)




- 2 (3%) 22 (96%) 53 (96%) 0.88
The pill should be taken at approximately the 
same time every day
*75 (94%) 3 (4%) 2 (3%) - 23 (100%) 51 (93%) 0.18
It is acceptable to continue taking active 
tablets without taking the inactive tablets in 
between
*43 (54%) 16 (20%) 21 (26%) - 12 (52%) 31 (56%) 0.73
The pill is the most effective form of 
contraception currently available when used 
correctly
44 (55%) *22 (28%) 14 (18%) - 3 (13%) 19 (35%) 0.054
It is possible to fall pregnant while taking the 
pill even with perfect use
*63 (79%) 10 (13%) 6 (8%) 1 (1%) 16 (70%) 45 (82%) 0.23
It is important to take a break from using the 
pill
26 (33%) *20 (25%) 34 (43%) - 6 (26%) 14 (25%) 0.95
Q10. Factors that may reduce the contraceptive benefit of the COCP (* indicates the correct answer)
Missing one active pill by less than 12 hours 25 (31%) *34 (43%) 17 (21%) 4 (5%) 11 (48%) 23 (42%) 0.62
Missing one active pill by more than 12 hours *67 (84%) 6 (8%) 7 (9%) - 19 (83%) 48 (87%) 0.58
Missing more than one active pill *75 (94%) 1 (1%) 3 (4%) 1 (1%) 23 (100%) 51 (93%) 0.18
Missing one or more inactive pill/s 22 (28%) *43 (54%) 14 (18%) 1 (1%) 14 (61%) 28 (51%) 0.42
St John’s Wort herbal preparation *16 (20%) 9 (11%) 55 (69%) - 5 (22%) 11 (20%) 0.86
Epilepsy medications such as phenytoin or 
carbamazepine
*11 (14%) 3 (4%) 66 (83%) - 3 (13%) 8 (15%) 0.86
Vomiting *63 (79%) 5 (6%) 12 (15%) - 19 (83%) 44 (80%) 0.79
Severe diarrhoea *49 (61%) 10 (13%) 21 (27%) - 15 (65%) 34 (62%) 0.78
Smoking 6 (8%) *36 (45%) 38 (48%) - 9 (39%) 26 (47%) 0.51
Antibiotics such as rifampicin and rifabutin *53 (66%) 3 (4%) 24 (30%) - 14 (61%) 38 (69%) 0.48
Other antibiotics
(When taken without side-effects like 
vomiting/diarrhoea)
53 (66%) *2 (3%) 25 (31%) - 0 (0%) 2 (4%) 0.35
Minor alcohol consumption
(e.g. an occasional alcoholic drink/s not on a 
regular basis)
6 (8%) *52 (65%) 22 (28%) - 17 (74%) 35 (64%) 0.38
Excessive alcohol consumption
(e.g. drinking amounts that cause vomiting, 
diarrhoea, poor  concentration or memory, or 
significant liver damage)
*43 (54%) 13 (16%) 24 (30%) - 10 (43%) 32 (58%) 0.23
* Percentages calculated using the total sample (n = 80)
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Question 12 of the survey asked women to identify factors that can 
potentially increase a women’s risk of thromboembolism while taking 
the COCP. The most frequently identified risk factors were smoking and 
obesity (selected by 74% and 69% of participants, respectively). Only 
38% correctly identified all three risk factors, which also includes age 
greater than 35 years [11,14]. 
Information sources 
Participants were asked where they source information regarding the 
COCP for question 13 of the survey. “General practitioner” was the 
most frequently selected option at 90% (n = 72). Further response 
details are shown in Figure 1. 
Total knowledge score
The mean total knowledge score for all participants was 14.4 (SD = 
4.86) out of a possible 34 (range = 5 to 26). The mean total knowledge 
score for current COCP users was 14.0 (SD = 4.81), with previous COCP 
users achieving a mean score of 14.8 (SD = 4.75). Women who had 
never used the COCP achieved a mean total knowledge score of 6.5. 
There was no significant difference in total knowledge score between 
current and previous users of the COCP (p = 0.56). 



















Ectopic pregnancy *7 (9%) 18 (23%) 11 (14%) 44 (55%) - 2 (9%) 4 (7%) 0.83
Birth defects 2 (3%) *33 (41%) 8 (10%) 37 (46%) - 4 (17%) 29 (53%) 0.004
Infertility 3 (4%) *30 (38%) 14 (18%) 33 (41%) - 9 (39%) 21 (38%) 0.94
Cardiovascular disease
(stroke, hypertension, clots) 2 (3%) 14 (18%) *31 (39%) 33 (41%) - 10 (43%) 21 (38%) 0.66
Benign breast disease *4 (5%) 17 (21%) 16 (20%) 42 (53%) 1 (1%) 0 (0%) 4 (7%) 0.18
Functional ovarian cysts *9 (11%) 12 (15%) 11 (14%) 47 (59%) 1 (1%) 4 (17%) 5 (9%) 0.29
Endometriosis-associated pain *22 (28%) 9 (11%) 3 (4%) 45 (56%) 1 (1%) 8 (35%) 14 (25%) 0.41
Breast cancer 4 (5%) 17 (21%) *18 (23%) 41 (51%) - 6 (26%) 13 (22%) 0.82
Ovarian cancer *5 (6%) 18 (23%) 11 (14%) 46 (58%) - 2 (9%) 3 (5%) 0.59
Endometrial cancer *5 (6%) 18 (23%) 7 (9%) 50 (63%) - 1 (4%) 4 (7%) 0.63
Menstrual disturbances *48 (60%) 6 (8%) 9 (11%) 13 (16%) 4 (5%) 12 (52%) 35 (64%) 0.35
Acne *45 (56%) 4 (5%) 14 (18%) 16 (20%) 1 (1%) 11 (48%) 33 (60%) 0.32
Weight gain 1 (1%) *4 (5%) 60 (75%) 13 (16%) 2 (3%) 1 (4%) 3 (5%) 0.84
Pelvic inflammatory disease *6 (8%) 14 (18%) 9 (11%) 50
(63%)
1 (1%) 2 (9%) 4 (7%) 0.83
Sexually transmitted infections 4 (5%) *47 (59%) 7 (9%) 20 (25%) 2 (3%) 11 (48%) 36 (65%) 0.12
Table 4. Participant responses regarding effects of the COCP on level of risk for various conditions. 
Figure 1. Survey participants’ information sources regarding the COCP.
* Indicates the correct answer
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Discussion
This study has found deficiencies in women’s knowledge of the COCP 
in all domains that were assessed. This finding is consistent with the 
available literature [11,19,21-24]. For the purpose of this study, a score 
of 80% or above for each individual response item was designated as 
an adequate level of knowledge. The rationale for stating an arbitrary 
value such as this was influenced by a recent systematic review by 
Hall et al. [19]. Though many studies concluded women have a poor 
level of knowledge regarding oral contraceptives, Hall et al. stated that 
of the studies they included for review, “what constituted deficient 
or adequate knowledge was not clearly defined”. The majority of 
women did not score above the required 80% correct responses to be 
considered adequate knowledge. No significant differences were found 
in the number of correct responses per question between current COCP 
users and previous users except for one question regarding whether 
the COCP has an effect on the risk of birth defects occurring (p = 0.004). 
Furthermore, the total knowledge score for both current and previous 
COCP users was less than 50% of the possible maximum score. 
Several key findings discussed below stand out as being important 
focus areas for improved contraceptive counselling.
COCP use and effectiveness
This study revealed that 55% of women believe the COCP is the most 
effective form of contraception currently available when used correctly, 
with only 13% of current COCP users correctly identifying that it is not. 
Examples of contraception that have a better failure rate profile than 
the COCP include long-acting reversible contraceptives (LARC) such as 
the implantable rod (typical and perfect-use failure rate 0.05%), and 
intrauterine devices such as the Mirena (typical and perfect-use failure 
rate 0.2%) [17].
Women were not aware that antibiotics (other than rifampicin and 
rifabutin) were no longer considered to have a negative impact on the 
contraceptive effect of the COCP [25], with 66% of women indicating 
that taking antibiotics (without side effects such as vomiting and 
diarrhoea) would reduce the contraceptive effect of the COCP. 
There were mixed results regarding whether it is important to take a 
break from the COCP with 25% of women correctly identifying there 
is no requirement for a break. Interestingly, Philipson, Wakefield, and 
Kasparian [11] found that 25.6% of their participants thought that 
it was healthy to stop COCP use for a while (length of time was not 
stipulated in the question). 
Mechanism of action
Only 58% of women correctly identified the main mechanism by which 
the COCP works, with 3% correctly identifying all three mechanisms. A 
systematic review by Hall et al. [19] found that understanding of the 
mechanism of action is infrequently assessed in similar studies. A study 
by Rajasekar and Bigrigg [23] not included in the aforementioned review 
found that 81.5% of women understood that the oral contraceptive 
prevented ovulation every month, but that 32% also thought that it 
killed sperm. 
Risks of COCP use
Of the study participants, 39% correctly identified that the COCP 
increases the risk for cardiovascular disease (hypertension, stroke, and 
other thromboembolic events). Similarly, Philipson, Wakefield, and 
Kasparian [11] found that 46.5% women identified an increase in blood 
clots. Although 74% of women in our study identified smoking as a 
factor that when combined with the COCP increases thromboembolism 
risk further, only 38% of women correctly identified all three risk 
factors (obesity, age over 35 years, and smoking).
Women appear to erroneously believe that the COCP causes weight 
gain (75% of respondents). A causal relationship has never been 
established. A Cochrane Review has found there is no significant 
difference in weight change between placebo and those taking 
combined contraceptives, though further research was indicated [26]. 
Previous studies suggest similar results. Fletcher, Bryden, and Bonin 
[27] found that 30.6% of respondents were concerned about weight 
gain on the pill, with 23.4% of respondents reporting weight gain as 
an experienced side effect. Gaudet et al. [28] found that 51.5% of 
respondents thought weight would increase on the pill.
Only 59% of women were aware that the COCP has no effect on 
contracting STIs, with 48% of current COCP users identifying the correct 
answer. This result is lower than that found by Philipson, Wakefield, 
and Kasparian [11] with 81.3% of their respondents identifying the 
correct answer. 
Benefits of COCP use 
There was a low level of understanding regarding decreased ovarian and 
endometrial cancer risk, but a better (though still low) understanding 
that COCP use can improve acne and menstrual disturbances. Poor 
understanding about COCP benefits appears consistent among studies 
with Philipson, Wakefield, and Kasparian [11] finding 13.7% correctly 
identified that COCP use decreases ovarian cancer risk, with 10% 
identifying decreased risk of endometrial cancer.
Study limitations 
Noting that approximately 29% of this study sample is currently taking 
the COCP, one might consider that knowledge would be forgotten after 
having ceased the COCP or after changing contraceptive methods. 
Additionally, it cannot be expected that women will remember all 
details relating to the COCP, as with any medication. Significant 
limitations of this study include the small response rate, which is likely 
due to the self-selection of participants. A self-selection bias may also 
exist. We can see from the results that there were very few women 
who had never taken the pill completing the survey. We must consider 
whether this is a true representation, or whether this may reflect the 
fact that women who have previously taken or are currently taking 
the COCP are more likely to complete the survey (perhaps due to a 
perceived familiarity with the topic). As the study was conducted in 
a general practice, a bias may also exist towards women who are 
likely to attend such medical facilities. An additional limitation of this 
study is that data was generated out of a single general practice and 
therefore the results may reflect specific factors associated with the 
GPs working there. Due to how the study was implemented, it cannot 
be determined if the participants had ever received contraceptive 
counselling from the practitioners within this centre, or whether a 
single or multiple GPs from this practice may have been involved in 
the counselling and prescribing of the COCP. At the time the study 
was conducted, seven GPs were working within the practice and 
so participants are likely patients of a number of these GPs with no 
particular focus on an individual practitioner’s patient list. Both the 
self-selection and single-centre nature of this study means that the 
results cannot be generalised. The survey was developed after a 
review of current literature and did not come from a validated source. 
Assessment of the reading level of the survey and a pilot study prior to 
data collection would improve the validity of the findings. Additionally, 
statistical analysis was limited to current and previous COCP users as 
the sample of participants who had never used the COCP was too small 
to allow reliable calculations. 
Implication for clinical practice and future directions
A recent analysis of the Bettering the Evaluation and Care of Health 
(BEACH) data by Mazza et al. [1] found that COCP prescribing is a 
common focus of many GP consultations concerning contraceptive 
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management. Our study also indicated that GPs are the main source of 
information regarding the COCP. Given that the COCP is a prescription 
medication, routine medical consultations are required and offer 
ample opportunity for medical practitioners to ensure appropriate use 
and knowledge of the COCP. This is especially so since a total of 54% 
of participants in our study indicated they have been or were using 
the pill for more than five years.  In their study assessing Australian 
women’s knowledge of the COCP, Philipson, Wakefield, and Kasparian 
[11] found a positive correlation between duration of pill usage and 
level of knowledge. 
Although our study suggested that GPs are the main source of 
information regarding the COCP, there were many other information 
sources identified and so we cannot assume the subsequent level of 
knowledge of the surveyed participants is the result of GP intervention 
alone. Therefore, other healthcare professionals that may provide 
COCP counselling have a role in helping to improve women’s knowledge 
of the COCP. Given that the Internet, friends, and family members were 
also important information sources for women regarding the COCP, 
awareness and appropriate counselling is also necessary to identify 
and address any misinformation that women may have obtained from 
these sources.
This study provides a unique perspective in that it assesses rural 
Australian women’s knowledge of the COCP. The aforementioned study 
by Philipson, Wakefield, and Kasparian [11], whose data collection was 
generated randomly from each state, was the only other Australian 
study identified after examination of the literature. As our study was 
limited to a rural general practice setting, future research may wish to 
expand on this data by investigating other rural practices or compare 
results to metropolitan practices. 
Rural Australians experience poorer health outcomes compared to 
their metropolitan counterparts [29,30]. Health literacy is likely a 
contributing factor to such outcomes [30]. An analysis of the Adult 
Literacy and Life Skills Survey data from 2006 by the Australian Bureau 
of Statistics shows that health literacy levels are low across the board – 
42% of Australian urban populations were shown to have a literacy level 
of 3 (considered an adequate level) or greater; 38% and 39% of inner 
regional and remote populations, respectively also demonstrated a 
literacy level of 3 or greater. The outer regional populations possessed 
the lowest levels of people demonstrating a literacy level of 3 or 
greater at 36% [31]. In the context of the clinical environment, there 
is a paucity of literature available, but one recent study by Wong et 
al. [32] comparing health literacy of patients attending both a rural 
and an urban rheumatology practice found no significant difference 
between these groups. Despite research showing differences in health 
outcomes between rural and metropolitan populations of Australia 
[29,30], studies comparing the knowledge and health literacy of rural 
and metropolitan patients, particularly in relation to medications, 
proved difficult to find so we cannot extrapolate the findings of the 
current study to comment on whether a general knowledge deficit 
exists. 
Since this study was designed only to assess women’s level of 
knowledge about the COCP, and not factors associated with level of 
knowledge, further studies regarding what factors influence knowledge 
are also important. These may include factors relating to the primary 
care setting, such as: impact of consultation timing; exploring the 
discussions and resources used during COCP consultations and whether 
counselling deficiencies exist; assessing what information healthcare 
professionals deem clinically relevant or applicable on an individual 
patient basis, and whether this impacts upon what information is 
provided to patients and therefore what knowledge base they retain. 
Additional studies may wish to investigate the effectiveness of the 
product information sheet for the COCP, or whether women believe 
COCP information is easily accessible and where this can be obtained 
(for example, what limits women’s access to information from 
pharmacies or community health clinics). Future studies may also wish 
to explore whether rural specific issues (for example, more limited 
access to healthcare providers) play a role.
Furthermore, additional studies that evaluate practical strategies 
for improving knowledge and information retention should also 
be undertaken. In the systematic review by Hall et al. [19] only four 
studies assessed interventions and their impact on contraceptive pill 
knowledge. Three of the four studies noted improved knowledge in at 
least one domain, highlighting that an array of additional educational 
materials may be beneficial in improving counselling sessions [19]. 
As more Australian-specific data accumulates about women’s 
knowledge of the COCP, better public health initiatives and education 
strategies can be implemented to improve outcomes. The results of this 
study may encourage healthcare professionals to better understand 
and review areas of their own counselling sessions. Improvements 
may be achieved through better addressing how to use the COCP, what 
will affect its contraceptive benefit, and common misconceptions. 
Additionally, healthcare professionals can be assured they have 
provided appropriate informed consent by discussing risks, benefits, 
and alternative options [33]. In the long term, this may eventually lead 
to improvements in the typical failure rate of the COCP and reduce the 
rate of unintended pregnancies.
Conclusion
The women surveyed in this study appear to have substantial gaps in 
their knowledge of the COCP despite a high prevalence and duration of 
usage. Although many other sources were also utilised for information 
on the COCP, GPs were the main source of information. As such, this 
study provides insight into specific knowledge areas that require 
further education and clarification during COCP counselling sessions 
to encourage improved knowledge of the COCP by women, particularly 
those in the rural Australian general practice setting. 
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